The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease
Abstract
In recent years, nerve growth factor (NGF) has gained attention as a potential therapeutic agent for Alzheimer's disease (AD). To study the expression of NGF and its homologs, brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT-3), postmortem samples of hippocampus from AD and control donors were examined by in situ hybridization. Hybridization signal for BDNF, but not NGF or NT-3, was decreased in samples of hippocampus from donors with AD. Decreased transcript abundance of BDNF mRNA in hippocampi of individuals with AD was verified by an RNAase protection assay. These results suggest the possibility that decreased expression of BDNF may contribute to the progression of cell death in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Downregulation of BDNF expression leads to weakened BDNF signaling in AD.348”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [348]
Citations
Cites
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627
Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain.
Hofer, M., Pagliusi, S. R., Hohn, A., Leibrock, J., & Barde, Y. A. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07423.x · Cited by 1,017
Korsching, S., Auburger, G., Heumann, R., Scott, J., & Thoenen, H. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03791.x · Cited by 938
Ernfors, P., Wetmore, C., Olson, L., & Persson, H. (1990) · Neuron · doi:10.1016/0896-6273(90)90090-3 · Cited by 819
Neuron numbers and dendritic extent in normal aging and Alzheimer’s disease
Coleman, P. D., & Flood, D. G. (1987) · Neurobiology of Aging · doi:10.1016/0197-4580(87)90127-8 · Cited by 772
Alderson, R. F., Alterman, A. L., Barde, Y.-A., & Lindsay, R. M. (1990) · Neuron · doi:10.1016/0896-6273(90)90166-d · Cited by 685
Knüsel, B., Winslow, J. W., Rosenthal, A., Burton, L. E., Seid, D. P., Nikolics, K., & Hefti, F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.3.961 · Cited by 603
Self-citationPrimary structure and biological activity of a novel human neurotrophic factor
Rosenthal, A., Goeddel, D. V., Nguyen, T., Lewis, M., Shih, A., Laramee, G. R., Nikolics, K., & Winslow, J. W. (1990) · Neuron · doi:10.1016/0896-6273(90)90203-r · Cited by 556
Self-citationWidespread Expression of BDNF But Not NT3 by Target Areas of Basal Forebrain Cholinergic Neurons
Phillips, H. S., Hains, J. M., Laramee, G. R., Rosenthal, A., & Winslow, J. W. (1990) · Science · doi:10.1126/science.1688328 · Cited by 533
Self-citation
Cited by
Binder (2004) · doi:10.1080/08977190410001723308 · Cited by 1,481
Smith, M., Makino, S., Kvetnansky, R., & Post, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-03-01768.1995 · Cited by 1,440
Brain-derived neurotrophic factor and its clinical Implications
Bathina, S., & Das, U. N. (2015) · Archives of Medical Science · doi:10.5114/aoms.2015.56342 · Cited by 1,381
Transport of brain-derived neurotrophic factor across the blood–brain barrier
Pan, W., Banks, W. A., Fasold, M. B., Bluth, J., & Kastin, A. J. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00141-5 · Cited by 1,354
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
“348 This weakened signaling triggers the activation of JAK2/STAT3 and C/EBP β signaling pathways in the AD brain and inhibits downstream Akt signaling molecules, 349 thereby promoting the activation of asparagine endopeptidase (AEP; also called δ -secretase) to cleave APP and tau proteins.”
Background
Metadata
- Authors
- Phillips, H. S., Hains, J. M., Armanini, M., Laramee, G. R., Johnson, S. A., & Winslow, J. W.
- Affiliations
- Genentech (US)
- University of Southern California (US)
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 1991-11
- Volume
- 7
- Issue
- 5
- Pages
- 695-702
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W2055979394
- Cited by
- 921
- References
- 26
- Citations by year
- 2026: 15 · 2025: 19 · 2024: 29 · 2023: 27 · 2022: 36 · 2021: 31 · 2020: 44 · 2019: 32 · 2018: 38 · 2017: 43 · 2016: 43 · 2015: 35 · 2014: 41 · 2013: 38 · 2012: 32
- FWCI
- 19.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Neuron (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, brain-derived neurotrophic factor, BDNF mRNA, hippocampus, nerve growth factor, neurotrophin-3, neurotrophin expression, postmortem brain, neuronal cell death, gene expression
- MeSH terms
- Alzheimer Disease, Hippocampus, Humans, Nerve Growth Factors, Nerve Tissue Proteins, Nucleic Acid Hybridization, RNA, Messenger, Brain-Derived Neurotrophic Factor, Neurotrophin 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. https://app.cochat.ai/papers/10.1016/0896-6273(91)90273-3
- The paper
- Phillips, H. S., Hains, J. M., Armanini, M., Laramee, G. R., Johnson, S. A., & Winslow, J. W. (1991). BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron. https://doi.org/10.1016/0896-6273(91)90273-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.